𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Incidence of adverse treatment effects in parkinson's disease: Evidence from a large employer population

✍ Scribed by Davis, K.L.; Fitzgerald, T.P.; Meyers, J.; Kulkarni, A.; Svarvar, P.; Hewitt, D.J.

Book ID
122340603
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
71 KB
Volume
16
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Rimantadine in Parkinson's disease patie
Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: Report of a case series
✍ Carlos Singer; Spiridon Papapetropoulos; Manuel A. Gonzalez; Eugene L. Roberts; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 67 KB

## Abstract We report our experience with 7 consecutive patients with Parkinson's disease (PD) who received rimantadine (the α‐methyl derivative of amantadine) in substitution of amantadine due to peripheral side effects (lower limb edema, livedo reticularis). Mean age was 67.3 Β± 5.9 years, the mea

Prevalence, incidence, and treatments of
Prevalence, incidence, and treatments of Dupuytren’s disease in the United States: results from a population-based study
✍ Dana Britt DiBenedetti; Dat Nguyen; Laurie Zografos; Ryan Ziemiecki; Xiaolei Zho πŸ“‚ Article πŸ“… 2010 πŸ› Springer-Verlag,Elsevier Science 🌐 English βš– 199 KB

## Background This large population-based study was conducted to estimate the prevalence of Dupuytren’s disease in US adults and describe associated treatment patterns. ## Methods A total of 23,103 individuals from an Internet-based research panel representative of the US population completed a b